Free Trial

Adicet Bio (ACET) Competitors

Adicet Bio logo
$7.26 -0.89 (-10.92%)
Closing price 04:00 PM Eastern
Extended Trading
$7.24 -0.02 (-0.28%)
As of 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

ACET vs. ADMA, URI, GWW, FAST, and WCC

Should you buy Adicet Bio stock or one of its competitors? MarketBeat compares Adicet Bio with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Adicet Bio include ADMA Biologics (ADMA), United Rentals (URI), W.W. Grainger (GWW), Fastenal (FAST), and WESCO International (WCC).

How does Adicet Bio compare to ADMA Biologics?

Adicet Bio (NASDAQ:ACET) and ADMA Biologics (NASDAQ:ADMA) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, media sentiment, profitability, earnings and valuation.

Adicet Bio has a beta of 1.56, suggesting that its share price is 56% more volatile than the broader market. Comparatively, ADMA Biologics has a beta of 0.72, suggesting that its share price is 28% less volatile than the broader market.

Adicet Bio presently has a consensus target price of $48.80, indicating a potential upside of 572.18%. ADMA Biologics has a consensus target price of $19.00, indicating a potential upside of 138.39%. Given Adicet Bio's stronger consensus rating and higher possible upside, equities analysts plainly believe Adicet Bio is more favorable than ADMA Biologics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Adicet Bio
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.75
ADMA Biologics
1 Sell rating(s)
2 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.20

83.9% of Adicet Bio shares are owned by institutional investors. Comparatively, 75.7% of ADMA Biologics shares are owned by institutional investors. 3.4% of Adicet Bio shares are owned by insiders. Comparatively, 3.9% of ADMA Biologics shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

ADMA Biologics has higher revenue and earnings than Adicet Bio. Adicet Bio is trading at a lower price-to-earnings ratio than ADMA Biologics, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Adicet BioN/AN/A-$116.80M-$14.90N/A
ADMA Biologics$510.17M3.62$146.93M$0.6811.72

ADMA Biologics has a net margin of 32.43% compared to Adicet Bio's net margin of 0.00%. ADMA Biologics' return on equity of 39.98% beat Adicet Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
Adicet BioN/A -80.35% -65.44%
ADMA Biologics 32.43%39.98%28.08%

In the previous week, ADMA Biologics had 8 more articles in the media than Adicet Bio. MarketBeat recorded 9 mentions for ADMA Biologics and 1 mentions for Adicet Bio. ADMA Biologics' average media sentiment score of 0.29 beat Adicet Bio's score of -0.59 indicating that ADMA Biologics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Adicet Bio
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Negative
ADMA Biologics
3 Very Positive mention(s)
0 Positive mention(s)
5 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral

Summary

ADMA Biologics beats Adicet Bio on 10 of the 16 factors compared between the two stocks.

How does Adicet Bio compare to United Rentals?

Adicet Bio (NASDAQ:ACET) and United Rentals (NYSE:URI) are both trading companies & distributors companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, valuation, institutional ownership, earnings, media sentiment, risk and dividends.

United Rentals has a net margin of 15.32% compared to Adicet Bio's net margin of 0.00%. United Rentals' return on equity of 30.56% beat Adicet Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
Adicet BioN/A -80.35% -65.44%
United Rentals 15.32%30.56%9.23%

Adicet Bio currently has a consensus price target of $48.80, suggesting a potential upside of 572.18%. United Rentals has a consensus price target of $1,013.63, suggesting a potential downside of 5.06%. Given Adicet Bio's stronger consensus rating and higher possible upside, research analysts clearly believe Adicet Bio is more favorable than United Rentals.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Adicet Bio
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.75
United Rentals
1 Sell rating(s)
3 Hold rating(s)
12 Buy rating(s)
0 Strong Buy rating(s)
2.69

Adicet Bio has a beta of 1.56, indicating that its share price is 56% more volatile than the broader market. Comparatively, United Rentals has a beta of 1.81, indicating that its share price is 81% more volatile than the broader market.

In the previous week, United Rentals had 23 more articles in the media than Adicet Bio. MarketBeat recorded 24 mentions for United Rentals and 1 mentions for Adicet Bio. United Rentals' average media sentiment score of 1.62 beat Adicet Bio's score of -0.59 indicating that United Rentals is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Adicet Bio
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Negative
United Rentals
20 Very Positive mention(s)
3 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive

83.9% of Adicet Bio shares are owned by institutional investors. Comparatively, 96.3% of United Rentals shares are owned by institutional investors. 3.4% of Adicet Bio shares are owned by insiders. Comparatively, 0.5% of United Rentals shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

United Rentals has higher revenue and earnings than Adicet Bio. Adicet Bio is trading at a lower price-to-earnings ratio than United Rentals, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Adicet BioN/AN/A-$116.80M-$14.90N/A
United Rentals$16.10B4.15$2.49B$39.2027.24

Summary

United Rentals beats Adicet Bio on 12 of the 16 factors compared between the two stocks.

How does Adicet Bio compare to W.W. Grainger?

W.W. Grainger (NYSE:GWW) and Adicet Bio (NASDAQ:ACET) are both trading companies & distributors companies, but which is the better stock? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, dividends, risk, profitability, media sentiment and valuation.

W.W. Grainger has a net margin of 9.70% compared to Adicet Bio's net margin of 0.00%. W.W. Grainger's return on equity of 47.87% beat Adicet Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
W.W. Grainger9.70% 47.87% 21.84%
Adicet Bio N/A -80.35%-65.44%

W.W. Grainger currently has a consensus target price of $1,212.88, indicating a potential downside of 6.76%. Adicet Bio has a consensus target price of $48.80, indicating a potential upside of 572.18%. Given Adicet Bio's stronger consensus rating and higher probable upside, analysts clearly believe Adicet Bio is more favorable than W.W. Grainger.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
W.W. Grainger
1 Sell rating(s)
5 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.22
Adicet Bio
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.75

In the previous week, W.W. Grainger had 15 more articles in the media than Adicet Bio. MarketBeat recorded 16 mentions for W.W. Grainger and 1 mentions for Adicet Bio. W.W. Grainger's average media sentiment score of 1.56 beat Adicet Bio's score of -0.59 indicating that W.W. Grainger is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
W.W. Grainger
15 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Adicet Bio
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Negative

W.W. Grainger has a beta of 1.04, indicating that its share price is 4% more volatile than the broader market. Comparatively, Adicet Bio has a beta of 1.56, indicating that its share price is 56% more volatile than the broader market.

80.7% of W.W. Grainger shares are owned by institutional investors. Comparatively, 83.9% of Adicet Bio shares are owned by institutional investors. 6.3% of W.W. Grainger shares are owned by insiders. Comparatively, 3.4% of Adicet Bio shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

W.W. Grainger has higher revenue and earnings than Adicet Bio. Adicet Bio is trading at a lower price-to-earnings ratio than W.W. Grainger, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
W.W. Grainger$17.94B3.42$1.71B$37.1834.99
Adicet BioN/AN/A-$116.80M-$14.90N/A

Summary

W.W. Grainger beats Adicet Bio on 10 of the 16 factors compared between the two stocks.

How does Adicet Bio compare to Fastenal?

Fastenal (NASDAQ:FAST) and Adicet Bio (NASDAQ:ACET) are both trading companies & distributors companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, institutional ownership, dividends, earnings, profitability, media sentiment, analyst recommendations and risk.

In the previous week, Fastenal had 9 more articles in the media than Adicet Bio. MarketBeat recorded 10 mentions for Fastenal and 1 mentions for Adicet Bio. Fastenal's average media sentiment score of 0.95 beat Adicet Bio's score of -0.59 indicating that Fastenal is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Fastenal
5 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Adicet Bio
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Negative

Fastenal has a beta of 0.73, suggesting that its share price is 27% less volatile than the broader market. Comparatively, Adicet Bio has a beta of 1.56, suggesting that its share price is 56% more volatile than the broader market.

Fastenal has higher revenue and earnings than Adicet Bio. Adicet Bio is trading at a lower price-to-earnings ratio than Fastenal, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Fastenal$8.20B6.55$1.26B$1.1441.04
Adicet BioN/AN/A-$116.80M-$14.90N/A

81.4% of Fastenal shares are held by institutional investors. Comparatively, 83.9% of Adicet Bio shares are held by institutional investors. 0.3% of Fastenal shares are held by company insiders. Comparatively, 3.4% of Adicet Bio shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Fastenal presently has a consensus price target of $49.85, indicating a potential upside of 6.53%. Adicet Bio has a consensus price target of $48.80, indicating a potential upside of 572.18%. Given Adicet Bio's stronger consensus rating and higher probable upside, analysts clearly believe Adicet Bio is more favorable than Fastenal.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Fastenal
2 Sell rating(s)
6 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.23
Adicet Bio
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.75

Fastenal has a net margin of 15.39% compared to Adicet Bio's net margin of 0.00%. Fastenal's return on equity of 33.25% beat Adicet Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
Fastenal15.39% 33.25% 25.49%
Adicet Bio N/A -80.35%-65.44%

Summary

Fastenal beats Adicet Bio on 9 of the 15 factors compared between the two stocks.

How does Adicet Bio compare to WESCO International?

WESCO International (NYSE:WCC) and Adicet Bio (NASDAQ:ACET) are both trading companies & distributors companies, but which is the better business? We will contrast the two companies based on the strength of their institutional ownership, earnings, analyst recommendations, risk, profitability, dividends, media sentiment and valuation.

WESCO International presently has a consensus price target of $321.38, indicating a potential downside of 9.16%. Adicet Bio has a consensus price target of $48.80, indicating a potential upside of 572.18%. Given Adicet Bio's higher possible upside, analysts plainly believe Adicet Bio is more favorable than WESCO International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
WESCO International
0 Sell rating(s)
1 Hold rating(s)
7 Buy rating(s)
1 Strong Buy rating(s)
3.00
Adicet Bio
1 Sell rating(s)
1 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.75

93.8% of WESCO International shares are owned by institutional investors. Comparatively, 83.9% of Adicet Bio shares are owned by institutional investors. 2.6% of WESCO International shares are owned by company insiders. Comparatively, 3.4% of Adicet Bio shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

WESCO International has a beta of 1.53, meaning that its share price is 53% more volatile than the broader market. Comparatively, Adicet Bio has a beta of 1.56, meaning that its share price is 56% more volatile than the broader market.

WESCO International has a net margin of 2.79% compared to Adicet Bio's net margin of 0.00%. WESCO International's return on equity of 13.82% beat Adicet Bio's return on equity.

Company Net Margins Return on Equity Return on Assets
WESCO International2.79% 13.82% 4.12%
Adicet Bio N/A -80.35%-65.44%

In the previous week, WESCO International had 6 more articles in the media than Adicet Bio. MarketBeat recorded 7 mentions for WESCO International and 1 mentions for Adicet Bio. WESCO International's average media sentiment score of 0.85 beat Adicet Bio's score of -0.59 indicating that WESCO International is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
WESCO International
4 Very Positive mention(s)
0 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Adicet Bio
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Negative

WESCO International has higher revenue and earnings than Adicet Bio. Adicet Bio is trading at a lower price-to-earnings ratio than WESCO International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
WESCO International$23.51B0.73$640.20M$14.0725.15
Adicet BioN/AN/A-$116.80M-$14.90N/A

Summary

WESCO International beats Adicet Bio on 12 of the 15 factors compared between the two stocks.

Get Adicet Bio News Delivered to You Automatically

Sign up to receive the latest news and ratings for ACET and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ACET and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ACET vs. The Competition

MetricAdicet BioMED IndustryMedical SectorNASDAQ Exchange
Market Cap$76.19M$3.30B$6.44B$11.97B
Dividend YieldN/A2.36%2.69%5.32%
P/E Ratio-0.4918.6923.7723.66
Price / SalesN/A171.23488.5086.29
Price / CashN/A111.0341.3955.53
Price / Book0.446.519.766.39
Net Income-$116.80M$24.09M$3.56B$337.36M
7 Day Performance-22.02%-6.98%-3.19%-3.07%
1 Month Performance-14.84%-3.57%-0.11%0.37%
1 Year Performance-39.46%42.44%25.29%27.87%

Adicet Bio Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ACET
Adicet Bio
3.1737 of 5 stars
$7.26
-10.9%
$48.80
+572.2%
-35.6%$76.19MN/AN/A90
ADMA
ADMA Biologics
4.8 of 5 stars
$7.90
-1.0%
$19.00
+140.5%
-60.8%$1.85B$509.86M11.62530
URI
United Rentals
3.9974 of 5 stars
$998.03
+0.2%
$1,006.13
+0.8%
+55.4%$62.38B$16.10B25.4628,500
GWW
W.W. Grainger
3.3689 of 5 stars
$1,242.55
+0.7%
$1,212.88
-2.4%
+19.9%$58.27B$18.38B33.4222,100
FAST
Fastenal
3.309 of 5 stars
$43.99
-0.5%
$49.77
+13.1%
+15.4%$50.74B$8.20B38.5924,489

Related Companies and Tools


This page (NASDAQ:ACET) was last updated on 6/5/2026 by MarketBeat.com Staff.
From Our Partners